関連レポート

医薬品原薬(API)の世界市場：タイプ別、治療領域別2027年予測

サイト内検索

お探しの資料等をキーワード検索できます。英語検索も有効です。

出版元：Transparency Market Research 　 出版元について

発行年：2023年8月

定価 ：Single User License(1名様ライセンス)US$5,795(米国ドル)/Multi User License(5名様)$8,795 /Enterprise License $11,705

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

ご請求は円換算（お見積り日TTSレート）となります。

納品形態：PDF by Email

当調査レポートは英文180ページになります。

商品コード：TMR076

【レポート紹介】

リポソーム薬物送達の世界市場規模は2022年で47億ドル、2031年に100億ドル、市場の平均年成長率は8.5%で推移する見込みです。
がん治療、感染症対策、スキンケアにおけるの需要増加が、世界のリポソーム薬物送達市場の需要を促進すると予想されます。
当レポートでは、リポソーム薬物送達の市場予測-2031年、各種セグメント別市場分析(構造別、製品別、国地域別、等)、規制動向、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

■リポソーム薬物送達の世界市場予測2017-2031年

・市場規模(US$)

■構造別、市場-2031年

単層リポソーム
・小型
・大型
多層リポソーム
その他
※(市場規模US$)

■製品別、市場-2031年

リポソームドキソルビシン
リポソームパクリタキセル
リポソーム型アムホテリシンB
その他
※(市場規模US$)

■技術別、市場-2031年

ステルスリポソーム技術
非PEG化リポソーム技術
デポフォームリポソーム技術
※(市場規模US$)

■用途別、市場-2031年

真菌疾患
疼痛管理
がん治療
ウイルスワクチン
光線力学療法
※(市場規模US$)

■エンドユーザー別、市場-2031年

病院
専門センター
外来手術センター
その他
※(市場規模US$)

■主要国地域別市場-2031年

北米
・米国、カナダ
・その他北米
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
南米
・ブラジル、メキシコ
・その他南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析

市場ダイナミクス（促進要因、障壁、機会）
技術的進歩
規制動向
COVID-19の影響分析
競合状況
市場シェア分析

■リポソーム薬物送達の主要企業プロフィール動向

Johnson & Johnson Services, Inc.
Gilead Sciences, Inc.
Sun Pharmaceutical Industries Ltd.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Janssen Pharmaceuticals, Inc.
CELSION Corporation
Abbott
Ipsen Pharma
Spectrum Pharmaceuticals, Inc.
武田薬品工業株式会社

（全180頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

1. Preface

    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology
3. Executive Summary : Global Liposome Drug Delivery Market
4. Market Overview

    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Liposome Drug Delivery Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements
    5.2. Overview: Liposome Drug delivery Systems
    5.3. Regulatory Scenario
    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Liposome Drug Delivery Market Analysis and Forecast, by Liposome Structure

    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Liposome Structure, 2017-2031
        6.3.1. Unilamellar Liposomes
            6.3.1.1. Small
            6.3.1.2. Large
        6.3.2. Multilamellar liposomes
        6.3.3. Others
    6.4. Market Attractiveness Analysis, by Liposome Structure

7. Global Liposome Drug Delivery Market Analysis and Forecast, by Product

    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Product, 2017-2031
        7.3.1. Liposomal Doxorubicin
        7.3.2. Liposomal Paclitaxel
        7.3.3. Liposomal Amphotericin B
        7.3.4. Others
    7.4. Market Attractiveness Analysis, by Product

8. Global Liposome Drug Delivery Market Analysis and Forecast, by Technology

    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by Technology, 2017-2031
        8.3.1. Stealth Liposome Technology
        8.3.2. Non PEGylated Liposome Technology
        8.3.3. DepoFoam Liposome Technology
        8.3.4. Lysolipid Thermally Sensitive Liposome Technology
    8.4. Market Attractiveness Analysis, by Technology

9. Global Liposome Drug Delivery Market Analysis and Forecast, by Application

    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast, by Application, 2017-2031
        9.3.1. Fungal Diseases
        9.3.2. Cancer Therapy
        9.3.3. Pain Management
        9.3.4. Viral Vaccines
        9.3.5. Photodynamic Therapy
        9.3.6. Others
    9.4. Market Attractiveness Analysis, by Application

10. Global Liposome Drug Delivery Market Analysis and Forecast, by End-user

    10.1. Introduction & Definition
    10.2. Key Findings / Developments
    10.3. Market Value Forecast, by End-user, 2017-2031
        10.3.1. Hospitals
        10.3.2. Specialty Centers
        10.3.3. Ambulatory Surgical Centers
        10.3.4. Others
    10.4. Market Attractiveness Analysis, by End-user

11. Global Liposome Drug Delivery Market Analysis and Forecast, by Region

    11.1. Key Findings
    11.2. Market Value Forecast, by Region
        11.2.1. North America
        11.2.2. Europe
        11.2.3. Asia Pacific
        11.2.4. Latin America
        11.2.5. Middle East & Africa
    11.3. Market Attractiveness Analysis, by Region

12. North America Liposome Drug Delivery Market Analysis and Forecast

    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Liposome Structure, 2017-2031
        12.2.1. Unilamellar Liposomes
            12.2.1.1. Small
            12.2.1.2. Large
        12.2.2. Multilamellar liposomes
        12.2.3. Others
    12.3. Market Value Forecast, by Product, 2017-2031
        12.3.1. Liposomal Doxorubicin
        12.3.2. Liposomal Paclitaxel
        12.3.3. Liposomal Amphotericin B
        12.3.4. Others
    12.4. Market Value Forecast, by Technology, 2017-2031
        12.4.1. Stealth Liposome Technology
        12.4.2. Non PEGylated Liposome Technology
        12.4.3. DepoFoam Liposome Technology
        12.4.4. Lysolipid Thermally Sensitive Liposome Technology
    12.5. Market Value Forecast, by Application, 2017-2031
        12.5.1. Fungal Diseases
        12.5.2. Cancer Therapy
        12.5.3. Pain Management
        12.5.4. Viral Vaccines
        12.5.5. Photodynamic Therapy
        12.5.6. Others
    12.6. Market Value Forecast, by End-user, 2017-2031
        12.6.1. Hospitals
        12.6.2. Specialty Centers
        12.6.3. Ambulatory Surgical Centers
        12.6.4. Others
    12.7. Market Value Forecast, by Country, 2017-2031
        12.7.1. U.S.
        12.7.2. Canada
    12.8. Market Attractiveness Analysis
        12.8.1. By Liposome Structure
        12.8.2. By Product
        12.8.3. By Technology
        12.8.4. By Application
        12.8.5. By End-user
        12.8.6. By Country

13. Europe Liposome Drug Delivery Market Analysis and Forecast

    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Liposome Structure, 2017-2031
        13.2.1. Unilamellar Liposomes
            13.2.1.1. Small
            13.2.1.2. Large
        13.2.2. Multilamellar liposomes
        13.2.3. Others
    13.3. Market Value Forecast, by Product, 2017-2031
        13.3.1. Liposomal Doxorubicin
        13.3.2. Liposomal Paclitaxel
        13.3.3. Liposomal Amphotericin B
        13.3.4. Others
    13.4. Market Value Forecast, by Technology, 2017-2031
        13.4.1. Stealth Liposome Technology
        13.4.2. Non PEGylated Liposome Technology
        13.4.3. DepoFoam Liposome Technology
        13.4.4. Lysolipid Thermally Sensitive Liposome Technology
    13.5. Market Value Forecast, by Application, 2017-2031
        13.5.1. Fungal Diseases
        13.5.2. Cancer Therapy
        13.5.3. Pain Management
        13.5.4. Viral Vaccines
        13.5.5. Photodynamic Therapy
        13.5.6. Others
    13.6. Market Value Forecast, by End-user, 2017-2031
        13.6.1. Hospitals
        13.6.2. Specialty Centers
        13.6.3. Ambulatory Surgical Centers
        13.6.4. Others
    13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.7.1. Germany
        13.7.2. U.K
        13.7.3. France
        13.7.4. Italy
        13.7.5. Spain
        13.7.6. Rest of Europe
    13.8. Market Attractiveness Analysis
        13.8.1. By Liposome Structure
        13.8.2. By Product
        13.8.3. By Technology
        13.8.4. By Application
        13.8.5. By End-user
        13.8.6. By Country/Sub-region

14. Asia Pacific Liposome Drug Delivery Market Analysis and Forecast

    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast By Liposome Structure, 2017-2031
        14.2.1. Unilamellar Liposomes
            14.2.1.1. Small
            14.2.1.2. Large
        14.2.2. Multilamellar liposomes
        14.2.3. Others
    14.3. Market Value Forecast, by Product, 2017-2031
        14.3.1. Liposomal Doxorubicin
        14.3.2. Liposomal Paclitaxel
        14.3.3. Liposomal Amphotericin B
        14.3.4. Others
    14.4. Market Value Forecast, by Technology, 2017-2031
        14.4.1. Stealth Liposome Technology
        14.4.2. Non PEGylated Liposome Technology
        14.4.3. DepoFoam Liposome Technology
        14.4.4. Lysolipid Thermally Sensitive Liposome Technology
    14.5. Market Value Forecast, by Application, 2017-2031
        14.5.1. Fungal Diseases
        14.5.2. Cancer Therapy
        14.5.3. Pain Management
        14.5.4. Viral Vaccines
        14.5.5. Photodynamic Therapy
        14.5.6. Others
    14.6. Market Value Forecast, by End-user, 2017-2031
        14.6.1. Hospitals
        14.6.2. Specialty Centers
        14.6.3. Ambulatory Surgical Centers
        14.6.4. Others
    14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.7.1. China
        14.7.2. Japan
        14.7.3. India
        14.7.4. Australia & New Zealand
        14.7.5. Rest of Asia Pacific
    14.8. Market Attractiveness Analysis
        14.8.1. By Liposome Structure
        14.8.2. By Product
        14.8.3. By Technology
        14.8.4. By Application
        14.8.5. By End-user
        14.8.6. By Country/Sub-region

15. Latin America Liposome Drug Delivery Market Analysis and Forecast

    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Liposome Structure, 2017-2031
        15.2.1. Unilamellar Liposomes
            15.2.1.1. Small
            15.2.1.2. Large
        15.2.2. Multilamellar liposomes
        15.2.3. Others
    15.3. Market Value Forecast, by Product, 2017-2031
        15.3.1. Liposomal Doxorubicin
        15.3.2. Liposomal Paclitaxel
        15.3.3. Liposomal Amphotericin B
        15.3.4. Others
    15.4. Market Value Forecast, by Technology, 2017-2031
        15.4.1. Stealth Liposome Technology
        15.4.2. Non PEGylated Liposome Technology
        15.4.3. DepoFoam Liposome Technology
        15.4.4. Lysolipid Thermally Sensitive Liposome Technology
    15.5. Market Value Forecast, by Application, 2017-2031
        15.5.1. Fungal Diseases
        15.5.2. Cancer Therapy
        15.5.3. Pain Management
        15.5.4. Viral Vaccines
        15.5.5. Photodynamic Therapy
        15.5.6. Others
    15.6. Market Value Forecast, by End-user, 2017-2031
        15.6.1. Hospitals
        15.6.2. Specialty Centers
        15.6.3. Ambulatory Surgical Centers
        15.6.4. Others
    15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        15.7.1. Brazil
        15.7.2. Mexico
        15.7.3. Rest of Latin America
    15.8. Market Attractiveness Analysis
        15.8.1. By Liposome Structure
        15.8.2. By Product
        15.8.3. By Technology
        15.8.4. By Application
        15.8.5. By End-user
        15.8.6. By Country/Sub-region

16. Middle East & Africa Liposome Drug Delivery Market Analysis and Forecast

    16.1. Introduction
        16.1.1. Key Findings
    16.2. Market Value Forecast, by Liposome Structure, 2017-2031
        16.2.1. Unilamellar Liposomes
            16.2.1.1. Small
            16.2.1.2. Large
        16.2.2. Multilamellar liposomes
        16.2.3. Others
    16.3. Market Value Forecast, by Product, 2017-2031
        16.3.1. Liposomal Doxorubicin
        16.3.2. Liposomal Paclitaxel
        16.3.3. Liposomal Amphotericin B
        16.3.4. Others
    16.4. Market Value Forecast, by Technology, 2017-2031
        16.4.1. Stealth Liposome Technology
        16.4.2. Non PEGylated Liposome Technology
        16.4.3. DepoFoam Liposome Technology
        16.4.4. Lysolipid Thermally Sensitive Liposome Technology
    16.5. Market Value Forecast, by Application, 2017-2031
        16.5.1. Fungal Diseases
        16.5.2. Cancer Therapy
        16.5.3. Pain Management
        16.5.4. Viral Vaccines
        16.5.5. Photodynamic Therapy
        16.5.6. Others
    16.6. Market Value Forecast, by End-user, 2017-2031
        16.6.1. Hospitals
        16.6.2. Specialty Centers
        16.6.3. Ambulatory Surgical Centers
        16.6.4. Others
    16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        16.7.1. GCC Countries
        16.7.2. South Africa
        16.7.3. Rest of Middle East & South Africa
    16.8. Market Attractiveness Analysis
        16.8.1. By Liposome Structure
        16.8.2. By Product
        16.8.3. By Technology
        16.8.4. By Application
        16.8.5. By End-user
        16.8.6. By Country/Sub-region

17. Competition Landscape

    17.1. Market Player - Competition Matrix, by tier and size of companies
    17.2. Market Share Analysis, by Company, 2021
    17.3. Company Profiles
        17.3.1. Johnson & Johnson Services, Inc.
            17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.1.2. Product Portfolio
            17.3.1.3. Financial Overview
            17.3.1.4. SWOT Analysis
            17.3.1.5. Strategic Overview
        17.3.2. Gilead Sciences, Inc.
            17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.2.2. Product Portfolio
            17.3.2.3. Financial Overview
            17.3.2.4. SWOT Analysis
            17.3.2.5. Strategic Overview
        17.3.3. Sun Pharmaceutical Industries Ltd.
            17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.3.2. Product Portfolio
            17.3.3.3. Financial Overview
            17.3.3.4. SWOT Analysis
            17.3.3.5. Strategic Overview
        17.3.4. Novartis AG
            17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.4.2. Product Portfolio
            17.3.4.3. Financial Overview
            17.3.4.4. SWOT Analysis
            17.3.4.5. Strategic Overview
        17.3.5. Teva Pharmaceutical Industries Ltd
            17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.5.2. Product Portfolio
            17.3.5.3. Financial Overview
            17.3.5.4. SWOT Analysis
            17.3.5.5. Strategic Overview
        17.3.6. Janssen Pharmaceuticals, Inc.
            17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.6.2. Product Portfolio
            17.3.6.3. Financial Overview
            17.3.6.4. SWOT Analysis
            17.3.6.5. Strategic Overview
        17.3.7. CELSION Corporation
            17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.7.2. Product Portfolio
            17.3.7.3. Financial Overview
            17.3.7.4. SWOT Analysis
            17.3.7.5. Strategic Overview
        17.3.8. Abbott
            17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.8.2. Product Portfolio
            17.3.8.3. Financial Overview
            17.3.8.4. SWOT Analysis
            17.3.8.5. Strategic Overview
        17.3.9. Ipsen Pharma
            17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.9.2. Product Portfolio
            17.3.9.3. Financial Overview
            17.3.9.4. SWOT Analysis
            17.3.9.5. Strategic Overview
        17.3.10. Spectrum Pharmaceuticals, Inc.
            17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.10.2. Product Portfolio
            17.3.10.3. Financial Overview
            17.3.10.4. SWOT Analysis
            17.3.10.5. Strategic Overview
        17.3.11. Takeda Pharmaceutical Company Limited
            17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.11.2. Product Portfolio
            17.3.11.3. Financial Overview
            17.3.11.4. SWOT Analysis
            17.3.11.5. Strategic Overview

List of Tables

Table 01: Pipeline Analysis - Liposome Drug Delivery Systems

Table 02: Clinically Marketed Liposome Drugs

Table 03: Regulations - Principle difference between U.S., EU and India

Table 04: Regulatory Scenario Assessment - Administrative Requirements

Table 05: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 06: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 07: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027

Table 08: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Region, 2017-2027

Table 09: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country, 2017-2027

Table 10: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 11: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 12: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027

Table 13: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 14: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 15: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 16: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027

Table 17: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 18: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 19: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 20: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027

Table 21: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 22: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 23: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 24: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027

Table 25: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 26: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 27: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 28: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast, by Application, 2017-2027

List of Figures

Figure 01: Global Liposome Drug Delivery Market Snapshot

Figure 02: Global Liposome Drug Delivery Market Value (US$ Mn), by Region, 2022 and 2031

Figure 03: Therapeutic applications of liposomes in drug delivery

Figure 04: Advantages of liposome drug delivery system

Figure 05: Global Liposome Drug Delivery Market Value (US$ Mn) and Y-o-Y (%) Forecast, 2017-2027

Figure 06: Global Liposome Drug Delivery Market Value Share, by Product, 2022

Figure 07: Global Liposome Drug Delivery Market Value Share, by Technology, 2022

Figure 08: Global Liposome Drug Delivery Market Value Share, by Application, 2022

Figure 09: Global Liposome Drug Delivery Market Value Share, by Region, 2022

Figure 10: Regulatory Approval Process - U.S.

Figure 11: Regulatory Approval Process - Europe

Figure 12: Regulatory Approval Process - India

Figure 13: Global Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031

Figure 14: Global Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031

Figure 15: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liposomal Doxorubicin, 2017-2027

Figure 16: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liposomal Paclitaxel, 2017-2027

Figure 17: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liposomal Amphotericin B, 2017-2027

Figure 18: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027

Figure 19: Global Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031

Figure 20: Global Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031

Figure 21: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stealth Liposome Technology, 2017-2027

Figure 22: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Non-PEGylated Liposome Technology, 2017-2027

Figure 23: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DepoFoam Liposome Technology, 2017-2027

Figure 24: Global Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031

Figure 25: Global Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031

Figure 26: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fungal Diseases, 2017-2027

Figure 27: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pain Management, 2017-2027

Figure 28: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Therapy, 2017-2027

Figure 29: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Viral Vaccines, 2017-2027

Figure 30: Global Liposome Drug Delivery Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Photodynamic therapy, 2017-2027

Figure 31: Global Liposome Drug Delivery Market - Regional Outlook

Figure 32: Global Liposome Drug Delivery Market Value (US$ Mn) Forecast, 2017-2027

Figure 33: Global Liposome Drug Delivery Market Value Share Analysis, by Region, 2022 and 2031

Figure 34: Global Liposome Drug Delivery Market Attractiveness Analysis, by Region, 2017-2031

Figure 35: North America Liposome Drug Delivery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 36: North America Liposome Drug Delivery Market Value Share Analysis, by Country, 2022 and 2031

Figure 37: North America Liposome Drug Delivery Market Attractiveness Analysis, by Country, 2017-2031

Figure 38: North America Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031

Figure 39: North America Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031

Figure 40: North America Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031

Figure 41: North America Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031

Figure 42: North America Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031

Figure 43: North America Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031

Figure 44: Europe Liposome Drug Delivery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 45: Europe Liposome Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 46: Europe Liposome Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2017-2031

Figure 47: Europe Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031

Figure 48: Europe Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031

Figure 49: Europe Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031

Figure 50: Europe Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031

Figure 51: Europe Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031

Figure 52: Europe Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031

Figure 53: Asia Pacific Liposome Drug Delivery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 54: Asia Pacific Liposome Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 55: Asia Pacific Liposome Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2017-2031

Figure 56: Asia Pacific Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031

Figure 57: Asia Pacific Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031

Figure 58: Asia Pacific Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031

Figure 59: Asia Pacific Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031

Figure 60: Asia Pacific Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031

Figure 61: Asia Pacific Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031

Figure 62: Latin America Liposome Drug Delivery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 63: Latin America Liposome Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 64: Latin America Liposome Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2017-2031

Figure 65: Latin America Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031

Figure 66: Latin America Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031

Figure 67: Latin America Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031

Figure 68: Latin America Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031

Figure 69: Latin America Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031

Figure 70: Latin America Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031

Figure 71: Middle East & Africa Liposome Drug Delivery Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 72: Middle East & Africa Liposome Drug Delivery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 73: Middle East & Africa Liposome Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2017-2031

Figure 74: Middle East & Africa Liposome Drug Delivery Market Value Share Analysis, by Product, 2022 and 2031

Figure 75: Middle East & Africa Liposome Drug Delivery Market Attractiveness Analysis, by Product, 2017-2031

Figure 76: Middle East & Africa Liposome Drug Delivery Market Value Share Analysis, by Technology, 2022 and 2031

Figure 77: Middle East & Africa Liposome Drug Delivery Market Attractiveness Analysis, by Technology, 2017-2031

Figure 78: Middle East & Africa Liposome Drug Delivery Market Value Share Analysis, by Application, 2022 and 2031

Figure 79: Middle East & Africa Liposome Drug Delivery Market Attractiveness Analysis, by Application, 2017-2031